Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Leukemia, Myeloid, Acute 6 Neoplasm Metastasis 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Lung Neoplasms 3 Endometrial Neoplasms 3 Congenital Abnormalities 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Oropharyngeal Neoplasms 2 Neuroblastoma 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Anus Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Mitotane 4 Etoposide 3 Cisplatin 3 Doxorubicin 2 pegfilgrastim 1 Streptozocin 1 Platinum 1 Observation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Ethane 1 Dichlorodiphenyldichloroethane 1 Chemotherapy, Adjuvant 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adrenocortical Carcinoma × Observation × Clear all

NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡